You are here

A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Seaview A Quotient Clinical Business
Coral Gables, Florida, 33134 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Volunteers
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

• Healthy males or females between 18 and 65 years of age (both inclusive) with body mass
index between 19 and 30 kg/m2, inclusive, and body weight of not 95 kg, will be
enrolled in this study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Hematologic laboratory abnormalities (including leukocytosis [defined as total
leukocytes >11,000/mcL], leukopenia [defined as total leukocytes neutropenia [defined as absolute neutrophil count [defined as platelet count of laboratory evaluations.

- Lack of adequate hepatic or renal reserve.

- Any active systemic or immunologic disease or condition.

- History of biological growth factor exposure.

- Received live vaccination or exposure to communicable viral diseases within 4 weeks
prior to Screening.

NCT03273842
Pfizer
Completed
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now